This biotech stock is a bargain
Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, up nearly 16 percent. But with high returns come high valuations, except in one name, according to a strategist who closely watches the […]
I found some very interesting information when conducting research on small-cap biotech stocks. Most disturbing: Well-respected analysts recommended an abundance of small-cap biotech stocks that have since been annihilated. My job is to give readers ideas where they can start research to not only potentially make money, but to stay away from dangerous names. It’s not going to do any […]
Biotech Stocks and the Power of ContextInvestorEducation / Elliott Wave TheoryApr 27, 2015 – 10:13 PM GMTBy: EWIBiotech stocks: A real-life example of Elliott-wave forecasting at several degrees of trendSince joining Elliott Wave International in 1993, the editor of our Trader’s Classroom, Jeffrey Kennedy, has traveled to at least a dozen countries, teaching seminars to some of the best professional […]
View All4 Biotech Stocks Poised to Jump 15%It’s been something of a lackluster week for the broad market — but biotech has really shined.Source: FlickrWhile the S&P 500 was up just 1.3% as of Wednesday afternoon, biotechs as a group outperformed, gaining nearly 2.5%.7 Small-Cap Healthcare Stocks Set to Soar
This sector is famous for being a volatile one, so timing […]
Everyone likes a great deal, and there’s no biotech stock I’d love to see go on sale more than Celgene (NASDAQ: CELG).Celgene’s blockbuster drugs, industry-leading profitability, and rock-solid balance sheet put it among the elite companies in the business. As a result, the company hasn’t given investors too many chances to buy its shares at a bargain price. But if […]
Here’s how to protect your profits in biotech: Trader
Susquehanna’s Stacey Gilbert thinks biotech could be due for a pullback. She lays out an options strategy to protect your biotech holdings.
It’s been a record-breaking run for biotech stocks, with the Nasdaq Biotech ETF, the IBB, up 18 percent this year alone and nearly 300 percent in the past five years. But […]
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty stocks up by more than 30% this year. More than thirty stocks are up greater than 50% while six have more than doubled.The iShares Biotechnology ETF (IBB) is already up more than 20% less than 3 […]
There’s nothing better than getting a great value — and let’s face it, when the market tumbles, often great stocks get crushed too. That could end up being particularly true in biotech. Since 2013, the industry’s return has tripled the S&P 500’s return, and that may mean that with the market slipping lately, biotech’s leading names — including Celgene — […]
The Seven Financial Indicators of Highly Successful Biotech Stocks InvestingCompanies / BioTechFeb 21, 2015 – 10:41 AM GMTBy: Money_MorningErnie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don’t apply.Here’s why they don’t, and why seven of these critical financial indicators do…The Usual Ratios Don’t ApplyThe […]
A lot of markets are at crucial areas here. The US major indices are probably going to decide which direction longer term they want to go. They could continue range bound for awhile longer though unless the Patriots get a hold of the air in the futures markets. They are at the top of the trading range here. You can […]
